参考文献 [1] Lundberg IE et al.2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Su…

参考文献[1] Lundberg IE et al.2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol. 2017 Dec;69(12):2271-2282.[2] Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018 Sep;17(9):816-828.[3] 中国研究型医院学会呼吸病学专业委员会. 特发性炎性肌病相关间质性肺疾病诊断和治疗中国专家共识 [J] . 中华结核和呼吸杂志, 2022, 45(7) : 635-650.[4] 蒲传强. 特发性炎性肌病 [J] . 中华神经科杂志,2019,52( 5 ): 410-422.[5] 中国医疗保健国际交流促进会皮肤科分会, 国家皮肤与免疫疾病临床医学研究中心. 成人皮肌炎诊疗中国专家共识（2022年） [J] . 中华皮肤科杂志, 2022, 55(11) : 939-948.[6] 中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会, 儿童风湿免疫病联盟. 中国幼年皮肌炎诊断与治疗指南 [J] . 中华儿科杂志, 2022, 60(12) : 1236-1247.[7] Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021 Dec 2;7(1):86.[8] Wu JQ, Lu MP, Reed AM. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J Pediatr. 2020 Feb;16(1):31-43.[9] Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear Antibodies in Systemic Sclerosis: an Update. Clin Rev Allergy Immunol. 2020 Feb;58(1):40-51.[10] Pakozdi A, Nihtyanova S, Moinzadeh P, Ong VH, Black CM, Denton CP. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol.2011 Nov;38(11):2406-9.[11] Ranque B, et al. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol. 2010 Nov;39(6):498-505.[12] Satoh M, et al. Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others. Clin Rev Allergy Immunol. 2022 Oct;63(2):210-239.[13] Nagai A, et al. Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patients. J Neurol Sci. 2022 Nov 15;442:120391.[14] Höppner J, et al. Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis. Front Immunol. 2023 Jan 4;13:1045523.[15] Conrad K, et al. The Clinical Relevance of Anti-DFS70 Autoantibodies. Clin Rev Allergy Immunol. 2017 Apr;52(2):202-216.[16] Baroni SS, et al.Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 2006 Jun 22;354(25):2667-76.[17]Brito-Zerón P, et al. Sjögren syndrome. Nat Rev Dis Primers. 2016 Jul 7;2:16047.[18] Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev. 2009 Jun;8(7):632-7.[19] Wang X, Xia Y. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies. Front Immunol. 2019 Jul 17;10:1667.[20] Mahler M, et al. The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmun Rev.2012 Aug;11(10):771-5.[21] Lou H, Ling GS, Cao X. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target. J Autoimmun. 2022 Oct;132:102861.[22] Deng JS, Ballou B, Hofmeister JK. Internalization of anti-nucleolin antibody into viable HEp-2 cells. Mol Biol Rep. 1996;23(3-4):191-5.[23] Shang X,et al.Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Immun Inflamm Dis. 2021 Jun;9(2):407-418.[24] Ghirardello A, et al. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis. 2000 Dec;59(12):975-81.[25] Chen M, Zhao Q, Diao L, Xue K, Ruan Y, Xue F, Li J, Shi R, Pan M, Zheng J,Cao H. Distribution of anti-melanoma differentiation associated gene 5 (MDA5) IgG subclasses in MDA5+ dermatomyositis. Rheumatology (Oxford). 2021 Dec 24;61(1):430-439.